Belite Bio, Inc (BLTE)
NASDAQ: BLTE · Real-Time Price · USD
174.00
-5.12 (-2.86%)
At close: Mar 10, 2026, 4:00 PM EDT
177.39
+3.39 (1.95%)
After-hours: Mar 10, 2026, 6:00 PM EDT
Belite Bio Market Cap
Belite Bio has a market cap or net worth of $6.85 billion as of March 10, 2026. Its market cap has increased by 280.40% in one year.
Market Cap
6.85B
Enterprise Value
6.57B
1-Year Change
280.40%
Ranking
Category
Stock Price
$174.00
Market Cap Chart
Since the IPO on April 29, 2022, Belite Bio's market cap has increased from $144.57M to $6.85B, an increase of 4,634.77%. That is a compound annual growth rate of 171.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 10, 2026 | 6.85B | 14.07% |
| Dec 31, 2025 | 6.00B | 207.97% |
| Dec 31, 2024 | 1.95B | 54.32% |
| Dec 29, 2023 | 1.26B | 68.44% |
| Dec 30, 2022 | 749.63M | 418.52% |
| Apr 29, 2022 | 144.57M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Arrowhead Pharmaceuticals | 8.50B |
| Axsome Therapeutics | 8.41B |
| Nuvalent | 8.04B |
| Halozyme Therapeutics | 8.04B |
| Cytokinetics | 7.69B |
| Krystal Biotech | 7.56B |
| Kymera Therapeutics | 6.94B |
| Arcellx | 6.70B |